SEARCH

SEARCH BY CITATION

References

  • 1
    Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular Toxoplasmosis. II. Clinical Features, Pathology, and Management. Clin Exp Ophthalmol 2012; (in press).
  • 2
    Dubey JP. A review of toxoplasmosis in wild birds. Vet Parasitol 2002; 106: 12153.
  • 3
    Santos PS, Albuquerque GR, da Silva VM et al. Seroprevalence of Toxoplasma gondii in free-living Amazon River dolphins (Inia geoffrensis) from central Amazon, Brazil. Vet Parasitol 2011; 183: 1713.
  • 4
    Khan A, Fux B, Su C et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci U S A 2007; 104: 148727.
  • 5
    Boothroyd JC. Expansion of host range as a driving force in the evolution of Toxoplasma. Mem Inst Oswaldo Cruz 2009; 104: 17984.
  • 6
    Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 2000; 64: 60723.
  • 7
    Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998; 11: 26799.
  • 8
    Ogino N, Yoneda C. The fine structure and mode of division of Toxoplasma gondii. Arch Ophthalmol 1966; 75: 21827.
  • 9
    Kohler S, Delwiche CF, Denny PW et al. A plastid of probable green algal origin in apicomplexan parasites. Science 1997; 275: 14859.
  • 10
    Fichera ME, Roos DS. A plastid organelle as a drug target in apicomplexan parasites. Nature 1997; 390: 4079.
  • 11
    Mazumdar J, Wilson EH, Masek K, Hunter CA, Striepen B. Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii. Proc Natl Acad Sci U S A 2006; 103: 131927.
  • 12
    Dzierszinski F, Nishi M, Ouko L, Roos DS. Dynamics of Toxoplasma gondii differentiation. Eukaryot Cell 2004; 3: 9921003.
  • 13
    Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. J Protozool 1972; 19: 15577.
  • 14
    Frenkel JK, Ruiz A, Chinchilla M. Soil survival of toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 1975; 24: 43943.
  • 15
    Lindsay DS, Dubey JP. Long-term survival of Toxoplasma gondii sporulated oocysts in seawater. J Parasitol 2009; 95: 101920.
  • 16
    Jones JL, Dubey JP. Waterborne toxoplasmosis – recent developments. Exp Parasitol 2010; 124: 1025.
  • 17
    Silveira C, Vallochi AL, Rodrigues da Silva U et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 2011; 95: 396400.
  • 18
    Montoya JGARJ. Toxoplasmosis of the Central Nervous System. Boston, MA: Blackwell Scientific, 1997.
  • 19
    Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995; 172: 15616.
  • 20
    Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, Sibley LD. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 2011; 41: 64555.
  • 21
    Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 196576.
  • 22
    Boothroyd JC, Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol 2002; 5: 43842.
  • 23
    Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 35765.
  • 24
    Suzuki Y, Wong SY, Grumet FC et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 1996; 173: 2658.
  • 25
    Kamani J, Mani AU, Egwu GO, Kumshe HA. Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol 2009; 103: 31721.
  • 26
    Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res 2009; 11: 2059.
  • 27
    Bell A, Gill R, Isaac-Renton J et al. Outbreak of toxoplasmosis associated with municipal drinking water – British Columbia. The British Columbia Toxoplasmosis Team. Can Commun Dis Rep 1995; 21: 1613.
  • 28
    Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 2007; 77: 40510.
  • 29
    Nussenblatt RB, Belfort R Jr. Ocular toxoplasmosis. An old disease revisited. JAMA 1994; 271: 3047.
  • 30
    Silveira C, Belfort R Jr, Muccioli C et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001; 131: 3514.
  • 31
    Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in North Rio de Janeiro state, Brazil. Emerg Infect Dis 2003; 9: 5562.
  • 32
    Sobral CA, Amendoeira MR, Teva A, Patel BN, Klein CH. Seroprevalence of infection with Toxoplasma gondii in indigenous Brazilian populations. Am J Trop Med Hyg 2005; 72: 3741.
  • 33
    Diaz-Suarez O, Estevez J. Seroepidemiology of toxoplasmosis in women of childbearing age from a marginal community of Maracaibo, Venezuela. Rev Inst Med Trop Sao Paulo 2009; 51: 137.
  • 34
    Contreras M, Schenone H, Salinas P et al. Seroepidemiology of human toxoplasmosis in Chile. Rev Inst Med Trop Sao Paulo 1996; 38: 4315.
  • 35
    Rosso F, Les JT, Agudelo A et al. Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am J Trop Med Hyg 2008; 78: 5048.
  • 36
    Alvarado-Esquivel C, Estrada-Martinez S, Pizarro-Villalobos H, Arce-Quinones M, Liesenfeld O, Dubey JP. Seroepidemiology of Toxoplasma gondii infection in general population in a Northern Mexican city. J Parasitol 2011; 97: 403.
  • 37
    Terazawa A, Muljono R, Susanto L, Margono SS, Konishi E. High Toxoplasma antibody prevalence among inhabitants in Jakarta, Indonesia. Jpn J Infect Dis 2003; 56: 1079.
  • 38
    Dhumne M, Sengupta C, Kadival G, Rathinaswamy A, Velumani A. National seroprevalence of Toxoplasma gondii in India. J Parasitol 2007; 93: 15201.
  • 39
    Xiao Y, Yin J, Jiang N et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 2010; 10: 4.
  • 40
    Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 2009; 47: 12530.
  • 41
    Udonsom R, Lekkla A, Chung PT, Cam PD, Sukthana Y. Seroprevalence of Toxoplasma gondii antibody in Vietnamese villagers. Southeast Asian J Trop Med Public Health 2008; 39: 148.
  • 42
    Hofhuis A, van Pelt W, van Duynhoven YT et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect 2011; 139: 5308.
  • 43
    Fromont EG, Riche B, Rabilloud M. Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis 2009; 9: 76.
  • 44
    Ramos JM, Milla A, Rodriguez JC, Padilla S, Masia M, Gutierrez F. Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res 2011; 109: 144752.
  • 45
    Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect 2007; 13: 10127.
  • 46
    Morris A, Croxson M. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N Z Med J 2004; 117: U770.
  • 47
    Zarkovic A, McMurray C, Deva N, Ghosh S, Whitley D, Guest S. Seropositivity rates for Bartonella henselae, Toxocara canis and Toxoplasma gondii in New Zealand blood donors. Clin Experiment Ophthalmol 2007; 35: 1314.
  • 48
    Karunajeewa H, Siebert D, Hammond R, Garland S, Kelly H. Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust N Z J Obstet Gynaecol 2001; 41: 238.
  • 49
    Howe DK, Honore S, Derouin F, Sibley LD. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997; 35: 14114.
  • 50
    Khan A, Su C, German M, Storch GA, Clifford DB, Sibley LD. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol 2005; 43: 58817.
  • 51
    Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 2001; 184: 6339.
  • 52
    Fuentes I, Rubio JM, Ramirez C, Alvar J. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol 2001; 39: 156670.
  • 53
    Ajzenberg D, Cogne N, Paris L et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186: 6849.
  • 54
    Fekkar A, Ajzenberg D, Bodaghi B et al. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J Clin Microbiol 2011; 49: 15137.
  • 55
    Switaj K, Master A, Borkowski PK, Skrzypczak M, Wojciechowicz J, Zaborowski P. Association of ocular toxoplasmosis with type I Toxoplasma gondii strains: direct genotyping from peripheral blood samples. J Clin Microbiol 2006; 44: 42624.
  • 56
    Gallego C, Saavedra-Matiz C, Gomez-Marin JE. Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America). Acta Trop 2006; 97: 1617.
  • 57
    Ferreira IM, Vidal JE, Costa-Silva TA et al. Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Exp Parasitol 2008; 118: 2217.
  • 58
    Vallochi AL, Muccioli C, Martins MC, Silveira C, Belfort R Jr, Rizzo LV. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 2005; 139: 3501.
  • 59
    Khan A, Jordan C, Muccioli C et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 2006; 12: 9429.
  • 60
    Sibley LD, Khan A, Ajioka JW, Rosenthal BM. Genetic diversity of Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci 2009; 364: 274961.
  • 61
    Ronday MJ, Stilma JS, Barbe RF et al. Aetiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol 1996; 80: 95661.
  • 62
    Chesterton JR, Perkins ES. Ocular toxoplasmosis among Negro immigrants in London. Br J Ophthalmol 1967; 51: 61721.
  • 63
    Bella-Hiag A, Mvogo CE, Ellong A. [Uveitis: epidemiological aspects at the Hospital Laquintinie de Douala]. Ophthalmologica 2001; 215: 303.
  • 64
    Khairallah M, Yahia SB, Ladjimi A et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye (Lond) 2007; 21: 339.
  • 65
    Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010; 82: 4645.
  • 66
    London NJ, Hovakimyan A, Cubillan LD, Siverio CD Jr, Cunningham ET Jr. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. Eur J Ophthalmol 2011; 21: 8119.
  • 67
    Rodriguez A, Calonge M, Pedroza-Seres M et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996; 114: 5939.
  • 68
    Smith JA, Mackensen F, Sen HN et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology 2009; 116: 154451, 51 e1.
  • 69
    Glasner PD, Silveira C, Kruszon-Moran D et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992; 114: 13644.
  • 70
    de-la-Torre A, Gonzalez G, Diaz-Ramirez J, Gomez-Marin JE. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am J Ophthalmol 2007; 143: 3546.
  • 71
    de-la-Torre A, Lopez-Castillo CA, Gomez-Marin JE. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye (Lond) 2009; 23: 10903.
  • 72
    Gilbert RE, Dunn DT, Lightman S et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999; 123: 2839.
  • 73
    de-la-Torre A, Lopez-Castillo CA, Rueda JC, Mantilla RD, Gomez-Marin JE, Anaya JM. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Experiment Ophthalmol 2009; 37: 45866.
  • 74
    Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 2004; 52: 1215.
  • 75
    Das D, Bhattacharjee H, Bhattacharyya PK et al. Pattern of uveitis in North East India: a tertiary eye care center study. Indian J Ophthalmol 2009; 57: 1446.
  • 76
    Biswas J, Narain S, Das D, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol 1996; 20: 2238.
  • 77
    Yang P, Zhang Z, Zhou H et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30: 9438.
  • 78
    Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007; 51: 414.
  • 79
    Pathanapitoon K, Kunavisarut P, Ausayakhun S, Sirirungsi W, Rothova A. Uveitis in a tertiary ophthalmology centre in Thailand. Br J Ophthalmol 2008; 92: 4748.
  • 80
    Cimino L, Aldigeri R, Salvarani C et al. The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol 2010; 30: 5219.
  • 81
    Jakob E, Reuland MS, Mackensen F et al. Uveitis subtypes in a German interdisciplinary uveitis center – analysis of 1916 patients. J Rheumatol 2009; 36: 12736.
  • 82
    Wakefield D, Dunlop I, McCluskey PJ, Penny R. Uveitis: aetiology and disease associations in an Australian population. Aust NZ J Ophthalmol 1986; 14: 1817.
  • 83
    Chang JH, Landers J, Henderson TR, Craig JE. Prevalence of uveitis in indigenous populations presenting to remote clinics of Central Australia. Clin Experiment Ophthalmol 2011; (in press).
  • 84
    Guerina NG, Hsu HW, Meissner HC et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994; 330: 185863.
  • 85
    Webster JP, Lamberton PH, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006; 273: 102330.
  • 86
    Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 2009; 116: 2199205.
  • 87
    Mets MB, Holfels E, Boyer KM et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996; 122: 30924.
  • 88
    Safadi MA, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis 2003; 7: 32531.
  • 89
    Berrebi A, Assouline C, Bessieres MH et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 2010; 203: 552 e16.
  • 90
    Phan L, Kasza K, Jalbrzikowski J et al. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology 2008; 115: 5539 e8.
  • 91
    Phan L, Kasza K, Jalbrzikowski J et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 2008; 146: 37584.
  • 92
    Gilbert RE, Freeman K, Lago EG et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2008; 2: e277.
  • 93
    Havelaar AH, Kemmeren JM, Kortbeek LM. Disease burden of congenital toxoplasmosis. Clin Infect Dis 2007; 44: 146774.
  • 94
    Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 143642.
  • 95
    Kemmeren JM, Mangen MM-J, Van Duynhoven YTHP, Havelaar AH. Priority setting of foodborne pathogens-disease burden and costs of selected enteric pathogens. Priority Setting of Foodborne Pathogens-Disease Burden and Costs of Selected Enteric Pathogens. Bilthoven: National Institute for Public Health and the Environment (RIVM), 2006. RIVM Report 330080001/2006.
  • 96
    Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 2008; 38: 125778.
  • 97
    Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol 2008; 38: 135970.
  • 98
    Dubey JP. Distribution of cysts and tachyzoites in calves and pregnant cows inoculated with Toxoplasma gondii oocysts. Vet Parasitol 1983; 13: 199211.
  • 99
    Kijlstra A, Jongert E. Toxoplasma-safe meat: close to reality? Trends Parasitol 2009; 25: 1822.
  • 100
    Dubey JP, Hill DE, Jones JL et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 2005; 91: 108293.
  • 101
    Dubey JP, Rajendran C, Ferreira LR et al. High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA. Int J Parasitol 2011; 41: 82733.
  • 102
    Kijlstra A, Eissen OA, Cornelissen J, Munniksma K, Eijck I, Kortbeek T. Toxoplasma gondii infection in animal-friendly pig production systems. Invest Ophthalmol Vis Sci 2004; 45: 31659.
  • 103
    Dubey JP, Thulliez P, Powell EC. Toxoplasma gondii in Iowa sows: comparison of antibody titers to isolation of T. gondii by bioassays in mice and cats. J Parasitol 1995; 81: 4853.
  • 104
    Bowie WR, King AS, Werker DH et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997; 350: 1737.
  • 105
    de Moura L, Bahia-Oliveira LM, Wada MY et al. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 2006; 12: 3269.
  • 106
    Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010; 128: 2832.
  • 107
    Kniel KE, Lindsay DS, Sumner SS, Hackney CR, Pierson MD, Dubey JP. Examination of attachment and survival of Toxoplasma gondii oocysts on raspberries and blueberries. J Parasitol 2002; 88: 7903.
  • 108
    Lass A, Pietkiewicz H, Szostakowska B, Myjak P. The first detection of Toxoplasma gondii DNA in environmental fruits and vegetables samples. Eur J Clin Microbiol Infect Dis 2011; 31: 11018.
  • 109
    Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 97388.
  • 110
    Evengard B, Lilja G, Capraru T et al. A retrospective study of seroconversion against Toxoplasma gondii during 3,000 pregnancies in Stockholm. Scand J Infect Dis 1999; 31: 1279.
  • 111
    Kimball AC, Kean BH, Fuchs F. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. Am J Obstet Gynecol 1971; 111: 2118.
  • 112
    Lappalainen M, Koskela P, Hedman K et al. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis 1992; 24: 97104.
  • 113
    Sfameni SF, Skurrie IJ, Gilbert GL. Antenatal screening for congenital infection with rubella, cytomegalovirus and toxoplasma. Aust N Z J Obstet Gynaecol 1986; 26: 25760.
  • 114
    Muñoz Batet C, Guardià Llobet C, Juncosa Morros T et al. Toxoplasmosis y embarazo. Estudio multicentrico realizado en 16.362 gestantes de Barcelona. Med Clin (Barc) 2004; 123: 126.
  • 115
    Nobrega OT, Karnikowski MG. An estimation of the frequency of gestational toxoplasmosis in the Brazilian Federal District. Rev Soc Bras Med Trop 2005; 38: 35860.
  • 116
    Varella IS, Canti IC, Santos BR et al. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem Inst Oswaldo Cruz 2009; 104: 3838.
  • 117
    Gomez-Marin JE, de-la-Torre A, Angel-Muller E et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. Plos Negl Trop Dis 2011; 5: e1195.
  • 118
    Vaz RS, Thomaz-Soccol V, Sumikawa E, Guimaraes AT. Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res 2010; 106: 6615.
  • 119
    Sakikawa M, Noda S, Hanaoka M et al. Anti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol 2012; 19: 3657.
  • 120
    Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 182933.
  • 121
    Andrade GM, Vasconcelos-Santos DV, Carellos EV et al. Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J Pediatr (Rio J) 2010; 86: 858.
  • 122
    Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R Jr. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 2003; 136: 3701.
  • 123
    Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F. Reactivation of ocular toxoplasmosis during pregnancy. BJOG 2005; 112: 2412.
  • 124
    Alvarado-Esquivel C, Liesenfeld O, Marquez-Conde JA, Estrada-Martinez S, Dubey JP. Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, Mexico. J Parasitol 2010; 96: 84750.
  • 125
    Alvarado-Esquivel C, Liesenfeld O, Marquez-Conde JA et al. Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico. Zoonoses Public Health 2008; 55: 30612.
  • 126
    Cook AJ, Gilbert RE, Buffolano W et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000; 321: 1427.
  • 127
    Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49: 87884.
  • 128
    Alvarado-Esquivel C, Liesenfeld O, Estrada-Martinez S, Felix-Huerta J. Toxoplasma gondii infection in workers occupationally exposed to raw meat. Occup Med (Lond) 2011; 61: 2659.
  • 129
    Garcia JL, Navarro IT, Biazzono L et al. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route. Vet Parasitol 2007; 145: 197206.
  • 130
    Kijlstra A, Meerburg B, Cornelissen J, De Craeye S, Vereijken P, Jongert E. The role of rodents and shrews in the transmission of Toxoplasma gondii to pigs. Vet Parasitol 2008; 156: 18390.
  • 131
    Dubey JP, Kotula AW, Sharar A, Andrews CD, Lindsay DS. Effect of high temperature on infectivity of Toxoplasma gondii tissue cysts in pork. J Parasitol 1990; 76: 2014.
  • 132
    Hill DE, Benedetto SM, Coss C, McCrary JL, Fournet VM, Dubey JP. Effects of time and temperature on the viability of Toxoplasma gondii tissue cysts in enhanced pork loin. J Food Prot 2006; 69: 19615.
  • 133
    Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000; 49: 5968.